KalVista Pharmaceuticals Ratios (2014-2025) | KALV

Ratios Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Dec2024 Apr2025
Profitability
EBT Margin -33,583.33%-50,360.00%-39,240.00%-74,057.14%-83,342.86%-71,314.29%-80,800.00%-94,342.86%-523.69%-2,038.07%-3,270.16%-4,457.02%-5,678.13%-526.71%-185.84%-60.00%-186.12%-83.85%-152.62%-371.80%-266.37%-224.08%-783.26%-224.74%
EBIT Margin -30,933.33%-48,720.00%-35,680.00%-70,014.29%-80,957.14%-69,985.71%-79,557.14%-93,257.14%-525.13%-2,043.15%-3,272.98%-4,461.40%-5,680.21%-526.80%-186.44%-61.34%-188.52%-87.50%-171.21%-384.83%-283.88%-236.96%-806.85%-234.23%
EBITDA Margin -30,933.33%-48,720.00%-35,680.00%-70,014.29%-80,957.14%-69,985.71%-79,557.14%-93,257.14%90.77%-1,000.00%-3,015.32%-3,454.39%-5,012.50%-446.23%-120.12%-33.68%-170.79%-55.63%-98.23%-285.41%-219.62%-137.24%-583.96%-185.25%
Operating Margin -30,933.33%-48,720.00%-35,680.00%-70,014.29%-80,957.14%-69,985.71%-79,557.14%-93,257.14%-525.13%-2,043.15%-3,272.98%-4,461.40%-5,680.21%-526.80%-186.44%-61.34%-188.52%-87.50%-171.21%-384.83%-283.88%-236.96%-806.85%-234.23%
Net Margin -33,583.33%-50,360.00%-39,240.00%-74,057.14%-83,342.86%-71,314.29%-80,800.00%-94,342.86%-458.97%-2,152.79%-3,167.34%-3,685.96%-5,133.33%-442.41%-224.54%-13.57%-186.12%-83.85%-152.62%-371.80%-266.37%-224.08%-783.26%-224.74%
FCF Margin -29,250.00%-40,260.00%-32,310.00%-60,414.29%-93,142.86%-76,100.00%-77,800.00%-75,257.14%-584.31%-2,134.01%-4,535.08%-2,322.81%-4,747.92%-648.62%1,202.83%-145.43%-182.28%-161.07%-279.59%-368.63%-337.58%-202.24%-831.26%-330.18%
Efficiency
Assets Average 7.18M37.66M64.84M59.44M53.23M36.20M32.56M32.76M50.70M64.02M59.50M95.09M129.54M122.33M119.01M115.97M107.50M97.73M88.22M79.67M70.83M113.27M149.54M126.36M174.69M217.80M180.51M227.82M
Equity Average -46.58M5.18M56.97M51.97M46.19M33.09M29.03M28.91M29.82M27.91M26.75M66.60M105.49M100.39M99.30M99.83M93.77M86.75M79.09M69.71M61.77M98.95M126.89M101.51M147.58M189.69M153.40M149.18M
Invested Capital -39.75M-47.89M59.80M55.59M50.77M45.02M34.85M31.33M26.73M31.08M28.57M27.25M26.25M106.95M104.03M96.74M101.87M97.79M89.75M83.75M74.44M64.98M58.56M139.34M114.45M88.58M206.58M172.80M133.99M164.36M
Asset Utilization Ratio 0.000.000.000.000.000.040.020.050.070.130.200.170.140.130.130.120.110.13
Leverage & Solvency
Interest Coverage Ratio -23.20-29.35-9.99-5.86-33.53-51.57-63.28-74.18
Debt to Equity -0.10-0.090.080.080.090.11
Debt Ratio 0.670.580.070.070.080.09
Equity Ratio -6.65-6.350.880.880.870.870.920.910.870.890.430.440.460.810.820.820.850.870.870.910.890.860.880.870.820.780.880.860.830.56
Times Interest Earned -23.20-29.35-9.99-5.86-33.53-51.57-63.28-74.18
Valuation
Enterprise Value -9.28M-7.18M-9.32M-3.90M193.69M99.13M34.09M-37.92M-29.10M-1.38M3.12M46.73M41.79M43.87M95.52M53.91M40.47M53.07M203.58M210.80M295.88M188.11M95.38M105.02M126.98M111.11M252.32M222.41M222.50M188.91M469.40M268.44M447.10M311.70M150.23M684.58M
Market Capitalization 196.87M164.52M93.97M15.80M19.49M14.25M13.81M80.23M72.74M70.32M123.65M112.59M91.53M101.14M324.70M321.95M396.69M288.47M188.84M185.59M194.70M175.44M308.19M272.72M345.76M292.09M544.99M478.84M621.38M447.48M418.57M684.58M
Return Ratios
Return on Sales -454.70%-545.63%-687.38%-773.79%-824.50%-22.45%-18.03%-16.70%-14.54%-34.59%-15.51%-5.67%-2.22%-1.67%-1.14%-1.13%-1.76%-1.93%-2.45%-3.48%-3.05%
Return on Capital Employed 3.33%-0.49%-0.31%-0.38%-0.46%-0.67%-0.79%-0.84%-0.78%-0.46%-0.55%-0.26%-0.19%-0.29%-0.31%-0.35%-0.44%-0.45%-0.60%-0.68%-0.69%
Return on Assets -1.90%-0.46%-0.31%-0.36%-0.43%-0.62%-0.70%-0.75%-0.41%-0.29%-0.34%-0.20%-0.16%-0.23%-0.26%-0.30%-0.38%-0.40%-0.47%-0.54%-0.56%
Return on Equity 0.29%-3.37%-0.35%-0.42%-0.50%-0.67%-0.78%-0.85%-0.70%-0.67%-0.75%-0.28%-0.19%-0.28%-0.31%-0.35%-0.44%-0.45%-0.58%-0.64%-0.65%